Which has the lower trailing P/E, MEDP or SOLV?

SOLV has the lower trailing P/E: MEDP trades at 35.20 and SOLV at 10.99. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MEDP or SOLV?

Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus SOLV at 2.72%.

Is MEDP or SOLV more profitable?

MEDP runs the higher net margin — MEDP at 17.67% versus SOLV at 17.26%.

Medpace Holdings, Inc. (MEDP) vs Solventum Corporation (SOLV)

A side-by-side comparison of Medpace Holdings, Inc. and Solventum Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

MEDP

Medpace Holdings, Inc.

$16.77B

$600.81HealthcareDelayed quote: Sep 15, 2026, 10:05 AM EDT

SOLV

Solventum Corporation

$15.58B

$89.97HealthcareDelayed quote: Sep 15, 2026, 10:05 AM EDT

Total return — MEDP vs SOLV

growth of $100 · dividends reinvested · last 2y

MEDP +45.9% (+20.8%/yr)SOLV +9.3% (+4.6%/yr)MEDP compounded faster over this window

MEDP SOLV

MEDP vs SOLV: by the numbers

•MEDP is the larger company ($16.77B vs $15.58B market cap).
•SOLV trades at the lower trailing earnings multiple (10.99 vs 35.20 P/E), one valuation lens rather than an overall verdict.
•MEDP converts more revenue to profit (17.67% vs 17.26% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs 2.72% CAGR).

Metrics side by side

Valuation

Metric	MEDP	SOLV
P/E ratio	35.20	10.99
Forward P/E	34.13	12.57
P/S ratio	6.03	1.87
P/B ratio	38.65	3.25
EV / EBITDA	26.81	7.19
FCF yield	4.18%	N/A

Profitability

Metric	MEDP	SOLV
Gross margin	28.76%	54.69%
Operating margin	20.97%	24.99%
Net margin	17.67%	17.26%
ROE	113.29%	29.88%
ROIC	77.00%	15.85%

Growth (annualized)

Metric	MEDP	SOLV
Revenue CAGR (5Y)	22.03%	2.72%
EPS CAGR (5Y)	30.90%	6.26%
FCF CAGR (5Y)	23.40%	N/A
Total return CAGR (5Y)	25.09%	N/A

Frequently asked

Which has the lower trailing P/E, MEDP or SOLV?: SOLV has the lower trailing P/E: MEDP trades at 35.20 and SOLV at 10.99. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MEDP or SOLV?: Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus SOLV at 2.72%.
Is MEDP or SOLV more profitable?: MEDP runs the higher net margin — MEDP at 17.67% versus SOLV at 17.26%.

Go deeper

Full MEDP analysis Full SOLV analysis Interactive comparison tool

Dig into the metrics

Medpace P/E ratio Solventum P/E ratio Medpace ROE Solventum ROE Medpace operating margin Solventum operating margin Medpace revenue growth Solventum revenue growth Medpace free cash flow Solventum free cash flow

Medpace & Solventum appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.